Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_assertion type Assertion NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_head.
- NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_assertion wasGeneratedBy ECO_0000203 NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_provenance.
- NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_assertion wasDerivedFrom befree-2016 NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_provenance.
- NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_assertion SIO_000772 25670170 NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_provenance.
- NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_assertion evidence source_evidence_literature NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_provenance.
- NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_assertion description "[Taken together, our results offer a preclinical rationale to combine anti-IL6 and gefitinib to treat patients with advanced stage ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1262630.RA_k-HVKnKf2Ji4_OdRSXYEBvtxvo2slVMicdHwPPuHmc130_provenance.